BioSpace News Archive

A transdermal patch may help to mitigate some of the challenges patients face with the management of their schizophrenia.

Company is co-hosting a Breakfast Symposium with the Neurocritical Care Society

Nextleaf Solutions Ltd. (“Nextleaf”, “OILS”, or the “Company”) (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) a Vancouver-based extraction technology company that owns a portfolio of eight (8) issued and over 35 pending patents pertaining to industrial-scale extraction, purification and formulation of cannabinoids, announced today that it has entered into an agreement with its commercialization partner, Nextleaf Labs Ltd. (“Labs”

Numab Therapeutics AG today announced that effective October 1 it has appointed former Novartis CEO and Chairman Dr. Daniel Vasella to its Board of Directors.

Funding will help ColdQuanta advance its Quantum Core™ technology platform, leading to quantum signal processing systems, quantum positioning systems, and quantum computers

Company Also Expands Sales Team to Include Five Leaders with Extensive Neurovascular Experience

OncoSec Medical Incorporated (“OncoSec”) (Nasdaq: ONCS), a company developing late-stage intratumoral cancer immunotherapies, today announced the publication of new data in Clinical Cancer Research which highlighted TAVO™ (intratumoral plasmid IL-12 with electroporation) as a safe, feasibility and clinically meaningful therapy in patients with Merkel cell carcinoma (MCC), an aggressive form of skin cancer.

ViewRay, Inc. (NASDAQ: VRAY) today announced preliminary results for the third quarter 2019

Successful healthcare entrepreneur and industry executive uniquely positioned to help activate growth and scale

Mr. Dickinson joined Gilead in 2016 and has transformed the way that the company approaches corporate development, expanding the kinds of transactions executed and implementing a broader and more strategic approach to deal-making.